Clinic Visits for Opioid Safety

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Kaiser Permanente

Must be taking: Opioids

Disqualifiers: No PCP visit, Integrated Pain Service, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

14 Participants Needed

Trial Summary

What is the purpose of this trial?

This study will assess the impact of an opioid safety clinic intervention for patients prescribed chronic opioid therapy. Outcomes are visits to the clinic, naloxone dispensings, Prescription Drug Monitoring reviews, and Urine Drug Screens conducted

Eligibility Criteria

This trial is for patients on chronic opioid therapy. It's designed to see if an opioid safety clinic can help them use opioids more safely. The study will track how often they visit the clinic, get naloxone (a drug that reverses overdoses), check their prescriptions, and do urine tests.

Inclusion Criteria

I am on long-term opioid medication.

Patients in the KPCO chronic opioid registry

No Primary Care Physician (PCP) or MHC visit in the past 6 months

Exclusion Criteria

Not a pilot location

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive the Medication Health Center intervention, including education on opioid safety, naloxone provision, and adherence to monitoring

2 months

Multiple visits to the Medication Health Center

Follow-up

Participants are monitored for safety and effectiveness after the intervention, including Urine Drug Screens, Naloxone dispensing, and PDMP reviews

2 months

Treatment Details

Interventions

• MHC Outreach Intervention

Trial Overview The 'MHC Outreach Intervention' is being tested to promote safe use of opioids among patients who take these drugs regularly. The intervention includes visits to a special clinic focused on opioid safety.

Participant Groups

Group I: MHC Early Outreach Intervention Experimental Treatment 1 Intervention

Early implementation of a MHC outreach intervention program. Clinics in the early outreach intervention arm will be assigned to the MHC Direct patient outreach, where MHC staff will encourage patients to schedule an appointment with the MHC and primary care (PC) staff will be educated to encourage MHC visits.

Group II: MHC Delayed Outreach Intervention Active Control 1 Intervention

Clinics in the usual care/delayed intervention arm will deliver usual care through the health plan, pharmacy and clinicians. As part of usual care, patients at these clinics can access naloxone through physician prescription or standing orders.

Who Is Running the Clinical Trial?

Kaiser Permanente

Lead Sponsor

Trials

563

Recruited

27,400,000+